Editorial
Meet the Team


GP’s knowledge and attitude towards anxiety and depression in Abu Dhabi

Vaginal birth after caesarean section

Cefpodoxime versus trimethorim - sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in girls

How does family medicine clerkship affect the attitudes to family medicine specialization?


Management of the hospitalized patient with sleep disordered breathing


Study of nursing care of cardiac patients in C.C.U. and A&E, and the role of education and effective training in the optimization of the quality of healthcare in both departments

Estimation of Body Mass Index in Daquq district


Bilateral Epistaxis after face washing in a pond in a two year old child


Childhood Emergencies - case study


 

 


Dr Abdulrazak Abyad
MD,MPH, AGSF
Editorial office:
Abyad Medical Center & Middle East Longevity Institute
Azmi Street, Abdo Center,
PO BOX 618
Tripoli, Lebanon

Phone: (961) 6-443684
Fax:     (961) 6-443685
Email:
aabyad@cyberia.net.lb

 
 

Lesley Pocock
medi+WORLD International
572 Burwood Road,
Hawthorn 3122
AUSTRALIA
Emai
l
: lesleypocock

 


Management of the Hospitalized Patient With Sleep Disordered Breathing

 
AUTHORS

Dr. Abdullah Alsaeedi, MD, FRCPC
Respiratory & Sleep Medicine, Division of Internal Medicine,
Aljahra Hospital, Kuwait

Dr. Mohammed Albader MD, FRCPC
Respiratory Medicine, Alrashed Allergy Centre, Kuwait

CORRESPONDENCE

Dr. A. Alsaeedi. PO BOX 169, Aljahra 01003, Kuwait.
Email: alsaeedi44@hotmail.com


INTRODUCTION

Sleep disordered breathing (SDB) frequently comes to medical attention for the first time when patients are hospitalized for diagnosis and treatment of an associated condition (e.g., poorly controlled hypertension, myocardial infarction, congestive heart failure, stroke, or problems related to management of diabetes mellitus). Diagnosis of SDB is generally performed in a specialized facility, which is often inconvenient and expensive for the hospitalized patient. Expectant peri-operative management of patients with sleep apnea is critical, particularly if they are previously undiagnosed. An ideal diagnostic strategy for these patients has not been defined. Continuous positive airway pressure (CPAP) is the mainstay of treatment of patients with sleep apnea. Unfortunately, it is often difficult for very ill patients to tolerate CPAP, unless it is administered with a high level of expertise.

Sleep disordered breathing (SDB), particularly obstructive sleep apnea (OSA), is a prevalent condition that is often undiagnosed. The development of obstructive apnea events is related to upper-airway anatomy and function. The relative contribution of these factors may vary widely. Obstruction most often occurs when upper-airway muscle tone is decreased relative to wakefulness. The upper airway collapses, with inspiration leading to obstructed breathing. The patient restores breathing at the expense of sleep continuity only to enter another phase of obstruction as sleep returns. This repetitive cycle of disordered breathing often produces episodic hypoxemia, increased stimulation of the sympathetic nervous system, and poor sleep quality.[1] Other sleep-related respiratory disturbances include Cheyne-Stokes breathing and central sleep apnea (CSA), characterized by oscillation or absence of respiratory effort.[2]

Population studies of middle-aged adults indicate that approximately 9% of women and 24% of men have SDB.[3] It has been estimated that 5% of all adults in Western countries have undiagnosed sleep apnea.[4] Even a relatively mild degree of OSA may be associated with adverse consequences including excess mortality,[5, 6] coronary artery disease manifestation,[7] stroke,[8] insulin resistance,[9] and increased risk of automobile accidents.[10] Studies have concluded that subjects with SDB are more likely to use health care resources and services before diagnosis.[11, 12] Therefore, incidental hospitalization of a patient with OSA may present a valuable opportunity for diagnosis. It also represents a potential challenge in management.

The impact of SDB on medical and surgical patients has not been rigorously investigated because it is largely speculative. Episodic hypoxemia and poor sleep quality may compromise recovery from medical illnesses. Furthermore, it is reasonable to assume that patients whose upper-airway patency is compromised during sleep are also at risk following administration of analgesia and anesthesia. This paper will briefly review data by which we may estimate the likelihood that OSA is present in association with commonly encountered medical conditions. Some reasonable precautions to avoid complications of SDB in medical and surgical patients will be presented. Finally, the inherent difficulties of diagnosis and treatment of a sick patient not previously known to have SDB will be discussed.

Obstructive Sleep Apnea in Hospitalized Patients
It has been suspected for many years that OSA is causally linked to cardiovascular complications. Until recently, investigations, purported to demonstrate this association, have been criticized for not meeting currently accepted standards of evidence.[13] The strengths and weaknesses of more recent studies have been discussed elsewhere.[14-17] It is clear, however, that groups of patients undergoing treatment for a variety of conditions demonstrate an increase in the occurrence of daytime sleepiness, snoring, and OSA. These studies are relevant because they highlight the likelihood that SDB will be encountered in hospitalized patients.

Hypertension
The relation between hypertension and OSA is now well established.[5, 18, 19] Even mild SDB is associated with an increased risk of cardiovascular disease.[20] The prevalence of OSA in hypertensive patients is not known. However, patients with hypertension that is difficult to control are particularly likely to have OSA.[21] Logan et al.[22] found that 83% of patients with drug-resistant hypertension had apnea/hypopnea indices (AHI) >/= ten events per hour. Effective treatment of patients with sleep apnea may result in decreases in systolic and diastolic blood pressure.[23-25]

Coronary Artery Disease and Myocardial Infarction
Numerous studies have suggested that a high proportion of patients with coronary artery disease (CAD) have OSA. Using a non-laboratory based overnight recording device, Schäfer et al.[26] found a 30.5% prevalence of OSA (defined as an AHI >/= 10) in patients with angiographically proven coronary artery disease versus 19.7% in controls. Other studies have reported prevalence of OSA in patients with CAD ranging from 14-65%.[27-30] Peker et al.[31] highlight the potential importance of OSA in patients with CAD and conclude that the presence of OSA was independently associated with an increased risk of cardiovascular mortality. Death occurred in 37.5% of patients with OSA over a 5-year follow-up period compared with 9.3% in patients without OSA.

Stroke
There is a high prevalence of SDB after stroke. Dyken et al.[33] found OSA on polysomnography in 77% of men and 64% of woman with recent strokes compared with 23% and 14%, respectively, in controls. Studying patients with stroke and transient ischemic attacks, Bassetti and Aldrich[34]] found an AHI >/= 10 in 62.5% of patients and only 12.5% of control subjects. Obstructive and central sleep apneas are common occurrences immediately following first time stroke.[35] Good et al.[36] reported 40% of stroke patients admitted to a rehabilitation unit demonstrated OSA identified by oximetry and confirmed with polysomnography. Parra et al.[37] reported that 71% of first time TIA and stroke patients had AHI >/= 10 in the acute phase. Wessendorf, Teschler, and Wang[38] reported prevalence of 61%, 44%, 32%, and 22% based on AHI cutoff points of 5, 10, 15, and 20 respectively. Good et al.[36] found functional outcome to be significantly worse in stroke patients with SDB. By contrast, Parra et al.[37] and Iranzo et al.[39] did not find a significant effect of OSA on functional outcome.

Recently, Wessendorf et al.[40] and Sandberg et al.[41] conducted treatment trials with CPAP in stroke patients. Improvements in depressive symptoms, sense of well-being, and nocturnal blood pressure were reported. Sandberg et al.[41] emphasized that compliance with CPAP is a problem for stroke patients especially in the presence of delirium and cognitive impairment.

Diabetes Mellitus
As a result of obesity or as an independent consequence of SDB, OSA has recently been linked to type 2 diabetes. Two recent studies have examined the relation between OSA and insulin resistance. Punjabi et al.[42] found that an AHI >/= 5 demonstrated an independent relation to glucose intolerance and insulin resistance despite controlling for body mass index (BMI) and AHI. Ip et al.[43] confirmed this observation.

Al-Delaimy et al.[44] looked at the relation between snoring and diabetes in the Nurses’ Health Study cohort. After adjusting for age and BMI, they found that, over a 10-year follow-up period, occasional and regular snorers demonstrated a significant increase in diagnosis with type 2 diabetes.

 

  Gastroesophageal Reflux Disease
Many patients with OSA will experience painful heartburn and gastroesophageal reflux. The prevalence of this association has not been fully described.[45] Anecdotal experience suggests that patients with GERD frequently experience an improvement of symptoms with successful use of CPAP.[46]

Congestive Heart Failure
Up to 50% of patients with stable, medically treated heart failure will show signs of SDB, most often in the form of central sleep apnea.[47] Mortality in congestive heart failure patients with untreated SDB is much higher than in those with heart failure alone.[48] Treatment with CPAP has been shown to significantly decrease mortality in patients with end-stage heart failure and SDB.[49] A study by Sin et al.[50] showed that patients with central sleep apnea waiting for heart transplant treated with CPAP had a significant increase in transplant-free survival.

Effects of Analgesia and Anesthesia on Patients With Sleep Apnea
Several recent reviews have highlighted the importance of OSA as a potential risk for complications related to anesthesia and analgesia after surgery.[51-53] However, the magnitude of this problem has not been well defined.[54] One uncontrolled study found that 17% of patients with OSA receiving general anesthesia, developed complications related to airway management.[55] Many of the factors responsible for upper-airway compromise in sleep are also present with anesthesia.[56] Anesthetic agents and narcotic medications increase the tendency for the upper airway to collapse. Furthermore, these agents impair the arousal response that terminates an episode of apnea, thereby increasing apnea severity.[57] Anesthetic agents alter several characteristics of sleep but these effects are difficult to separate from the effects of pain, pain management, and sleep deprivation in the hospital.[58, 59] As pain decreases after surgery and the effects of sleep deprivation accumulate, many patients experience a rebound of REM sleep during which sleep apnea is often most severe.[60, 61] The relation between severity of apnea and risk of sedation is ill defined. Gupta et al.[62] reported that even mild OSA represented a risk for orthopedic patients.

Prevention of Complications During Surgery for Patients With Obstructive Sleep Apnea
The greatest problem facing the anesthesiologist attempting to minimize complications related to sleep apnea is the fact that many, if not most, patients with OSA are undiagnosed.[4] Often, the anesthesiologist’s contact with the patient before surgery is brief. Patients with known OSA should be advised to notify the surgeon and anesthesia personnel of that diagnosis. It is reasonable to consider postponing elective surgery for patients with historical and physical examination findings suggestive of sleep apnea until diagnosis and treatment can be accomplished. A high level of expectant monitoring is necessary for patients who must proceed with urgent or non-elective surgery. Of particular concern are patients who have previously undergone surgical therapy for sleep apnea because there is a significant tendency for relapse a few years after treatment.[63]

Preparation Before Surgery
Once it is established or suspected that the patient has sleep apnea, a number of precautions are essential. The hallmark of safety administering anesthesia to patients with OSA is the concept that the patient’s airway must be controlled at all times. Unsupervised sedation before surgery should be avoided. The patient’s airway should be secured with either an oropharyngeal or nasopharyngeal airway during induction. A 3-5 minute period of pre-oxygenation may provide a brief cushion of safety.

Anesthesia Management
A system for intubation over a fiberoptic scope should be available and used if there is any doubt regarding ability to intubate the patient. Paralyzing agents, even short-acting agents, should be used with caution.[64] A surgeon should be available to perform an emergency tracheotomy if necessary.

Problems with intubation may be avoided by use of local or regional anesthesia. However, sedation may be more dangerous than intubation with airway control in these patients. Extubation is perhaps the greatest danger for patients with sleep apnea. The patient must be sufficiently awake to protect his airway before extubation can be safely accomplished. If the possibility of the presence of sleep apnea has been overlooked, this may be the time when unexpected difficulties develop.

Management After Surgery
Patient-administered pain control systems should be used with caution. Orders for narcotic analgesics or sedative medications should not be written on an “as needed” basis. The patient using CPAP therapy at home should be allowed to bring his own equipment to the hospital. Close observation remains important because his ability to use this equipment unaided may be impaired after surgery. Also, it is possible that the effects of surgery and analgesia may alter the appropriate CPAP settings. If the patient has not used CPAP previously, it may be necessary to initiate this therapy empirically.

Diagnosis of Sleep Disordered Breathing
Diagnosis of SDB is most often based on a polysomnography performed in a specialized facility.[65] For polysomnography to be effective, the patient must be able to sleep for extended periods of time. The sleep-disrupting environment of the hospital is well recognized. There is likely to be significant impact on sleep quality and continuity resulting from pain, anxiety, as well as patient-monitoring procedures, medication administration, routine nursing care, and hospital noise. Significant OSA can occur even in the absence of any suggestive physical findings or history.[66, 67] Limited sleep studies may have some utility but the role of this technology has been inconsistently validated. Oximetry alone is of little value because it is inadvisable to allow a patient under the stress of acute illness or surgery to become hypoxemic. Furthermore, there can be no certainty that the patient’s sleep in the hospital is a valid reflection of sleep at home. Consequently, it may be necessary to initiate therapy for presumed sleep apnea on an empiric basis. It must be emphasized that the diagnosis must be confirmed when the patient has recuperated significantly.

Empiric Treatment With Continuous Positive Airway Pressure
Key features of successful use of CPAP include effective mask fitting, correct institution of an optimal pressure level, and adequate patient education. All of these keys are potentially compromised in the setting of care of an acutely ill patient. Patients clearly should be protected during nocturnal sleep as well as naps, which may occur anytime when a patient is hospitalized. Most CPAP masks are not designed to be worn 24 hours per day and may produce serious skin breakdown as well as discomfort. Recently introduced masks that cover the entire face, such as the Respironics Total (Respironics, Pittsburgh, PA) mask, have become popular for non-invasive ventilation in the critical care unit. It is surprisingly well tolerated and may represent a useful option for some patients.

CPAP, or more specifically bi-level CPAP, is being used increasingly frequently for noninvasive ventilation. As a result, most respiratory therapy departments are familiar with mask ventilation. Unfortunately, long-term compliance with this therapy is disappointing.[68, 69] Most patients with sleep apnea do not require bi-level CPAP. However, it is very important that patients being started on CPAP therapy for sleep apnea begin treatment under the best possible conditions. Otherwise, they are likely to discard the treatment when they return home and even refuse subsequent evaluation and management. Careful monitoring and support of patients treated with CPAP for OSA has been shown to improve compliance.[70, 71] Some attempt at titration of pressure to identify optimal CPAP settings should be performed. There may be a role for automatically adjusting CPAP devices. The potential benefits and limitations of this technology have recently been reviewed in detail.[72] It should be emphasised that auto-CPAP is not an adequate substitute for polysomnography testing when the patient has stabilized. Controlled studies of different CPAP modalities during the transition from hospital to home care are needed.

CONCLUSION

OSA is commonly encountered in patients hospitalized for conditions that may or may not be directly associated to SDB. This fact represents an opportunity for diagnosis and a challenge for management. Unfortunately, medical education has historically devoted minimal time to this aspect of human health and diseases.[73] Careful attention to reports of excessive sleepiness or other features of sleep apnea in the patient’s history must be taken seriously. Physical findings that predispose to airway compromise should be noted. Major complications of surgery may well be prevented if health care providers exercise due caution regarding SDB. Acute medical or surgical illness, particularly if the level of central nervous system function is affected by the illness or its treatment, may amplify SDB manifestations.

The ideal approach to diagnosis and therapy under these circumstances is unknown. The relation between OSA in the hospital setting and persistent OSA at home “after the dust has settled” is often unpredictable and may vary greatly depending on specific circumstances. For example, episodic hypoxemia in a hospitalized patient receiving opiates may not be a valid predictor of the presence or severity of sleep apnea after recuperation. In most cases, a presumptive diagnosis of SDB made in a hospitalized patient should be corroborated by a standard polysomnography evaluation when the patient is stable. Empiric use of self-adjusting or bi-level CPAP may be helpful in some circumstances. An unfavorable initial experience with CPAP can complicate long-term compliance. Therefore, positive airway pressure therapy must be applied with a high level of expertise in sick patients who are naive regarding this treatment.



.
REFERENCES

1. Kuna S, Remmers JE: Anatomy and physiology of upper airway obstruction. In Principles and Practice of Sleep Medicine, edn 3. Edited by Kryger MH, Roth T, Dement WC. Philadelphia: W.B. Saunders;2000:840-858
2. White DP: Central sleep apnea. In Principles and Practice of Sleep Medicine, edn 3. Edited by Kryger MH, Roth T, Dement WC. Philadelphia: W.B. Saunders;2000:827-839.
3. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged Adults. N Engl J Med 1993, 328:1230-1235.
4. Young T, Evans L, Finn L, et al.: Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle aged men and women. Sleep 1997, 20:705-706.
5. He J, Kryger MH, Zorick FJ, et al.: Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988, 94:9-14.
6. Coy TV, Dimsdale JE, Ancoli-Israel , et al.: The role of sleep-disordered breathing in essential hypertension. Chest 1996, 108:890-895.
7. Hung J, Whitford EG, Parsons RW, et al.: Association of sleep apnoea with myocardial infarction in men. Lancet 1990, 336:261-264.
8. Palomaki H, Partinen M, Erkinjuntti T, et al.: Snoring, sleep apnea syndrome, and stroke. Neurology 1992, 42:75-81.
9. Strohl KP: Invited commentary: to sleep, perchance to discover. Am J Epidemiol 2002, 155:394-395.
10. Aldrich MS: Automobile accidents in patients with sleep disorders. Sleep 1989, 12:487-494.
11. Kapur VK, Redline S, Nieto FJ, et al.: The relationship between chronically disrupted sleep and healthcare use. Sleep 2002, 25:289-296.
12. Smith R, Ronald J, Delaive K, et al.: What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 2002, 121:164-172.
13. Wright J, Johns R, Watt I, et al.: Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. Br Med J 1997, 314:851-860.
14. Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea. Am J Resp Crit Care Med 2002, 165:1217-1239.
15. Lindberg E, Gislason T: Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000, 4:411-433.
16. Lanfranchi P, Somers VK: Obstructive sleep apnea and vascular disease. Respir Res 2001, 2:315-319.
17. Pankow W, Lies A, Lohmann FW: Sleep-disordered breathing and hypertension. N Engl J Med 2000, 343:966.
18. Bixler EO, Vgontzas AN, Lin HM, et al.: Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160:2289-2295.
19. Young T, Peppard P, Palta M, et al.: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997, 157:1746-1752.
20. Nieto FJ, Young TB, Lind BK, et al.: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000, 283:1829-1836.
21. Lavie P, Hoffstein V: Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001, 24:721-725.
22. Logan AG, Perlikowski SM, Mente A, et al.: High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
23. Mayer J, Becker H, Brandenburg U, et al.: Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991, 79:84-92.
24. Suzuki M, Otsuka K, Guilleminault C: Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993, 16:545-549.
25. Wilcox I, Grunstein RR, Hedner JA, et al.: Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993, 16:539-544.
26. Schäfer H, Koehler U, Ewig S, et al.: Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999, 92:79-84.
27. Mooe T, Rabben T, Franklin KA, et al.: Sleep-disordered breathing in men with coronary artery disease. Chest 1996, 109:659-663.
28. Mooe T, Rabben T, Wiklund U, et al.: Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 1996, 101:251-256.
29. Hung J, Whitford EG, Parsons RW, et al.: Association of sleep apnoea with myocardial infarction in men. Lancet 1990, 336:261-264.
30. De Olazabal JR, Miller MJ, Cook WR, et al.: Disordered breathing and hypoxia during sleep in coronary artery disease. Chest 1982, 82:548-552.
31. Peker Y, Hedner J, Kraiczi H, et al.: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000, 162:81-86.
32. Mohsenin V: Sleep-related breathing disorders and risk of stroke. Stroke 2001, 32:1271-1278.
33. Dyken ME, Somers VK, Yamada T, et al.: Investigating the relationship between stroke and obstructive sleep apnoea. Stroke 1996, 27:401-407.
34. Bassetti C, Aldrich MS: Sleep apnoea in acute cerebrovascular disease; final report on 128 patients. Sleep 1999, 22:217-223.
35. Bassetti C, Aldrich MS, Quint D: Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 1997, 28:1765-1772.
36. Good DC, Henkle JG, Gelber D, et al.: Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996, 27:252-259.
37. Parra O, Arboix A, Bechich S, et al.: Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000, 161:375-380.
38. Wessendorf TE, Teschler H, Wang Y-M: Sleep-disordered breathing among patients with first-ever stroke. J Neurol 2000, 247:41-47.
 
39. Iranzo A, Santamaria J, Berenguer J, et al.: Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 2002, 58:911-916.
40. Wessendorf TE, Wang Y-M, Thilmann AF, et al.: Treatment of obstructive sleep apnoea with nasal continuous positive pressure in stroke. Eur Resp J 2001, 18:623-629.
41. Sandberg O, Franklin KA, Bucht G, et al.: Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Resp J 2001, 18:630-634.
42. Punjabi NM, Sorkin JD, Katzel LI, et al.: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677-682.
43. Ip MSM, Lam B, Ng MM, et al.: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
44. Al-Delaimy WK, Manson JE, Willett WC, et al.: Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 2002, 155:387-393.
45. Ing AJ, Ngu MC, Breslin AB: Obstructive sleep apnea and gastroesophageal reflux. Am J Med 2000, 108 (suppl 4a): 120S-125S.
46. Kerr P, Shoenut JP, Millar T, et al.: Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome. Chest 1992, 101:1539-1544.
47. Javaheri S, Parker TJ, Liming JD, et al.: Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998, 97:2154-2159.
48. Lanfranchi PA, Braghiroli A, Bosimini E, et al.: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999, 99:1435-1440.
49. Willson GN, Wilcox I, Piper AJ, et al.: Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep. Eur Respir J 2001, 17:1250-1257.
50. Sin DD, Logan AG, Fitzgerald FS, et al.: Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102:61-66.
51. Benumof JL: Obstructive sleep apnea in the adult obese patient: implications for airway management. J Clin Anesth 2001, 13:144-156.
52. Loadsman JA, Hillman DR: Anesthesia and sleep apnoea. Br J Anaesth 2001, 86:254-266.
53. Boushra NN: Anaesthetic management of obstructive sleep apnea patients. Can J Anaesth 1996, 43:599-616.
54. Cullen DJ: Obstructive sleep apnea and postoperative analgesia - a potentially dangerous combination. J Clin Anesth 2001, 13:83-85.
55. Erman MK, Loube DI: Perioperative complications in obstructive sleep apnea patients. Sleep Breathing 1997, 1:3-10.
56. Eastwood PR, Szollosi I, Platt PR, et al.: Comparison of upper airway collapse during general anesthesia and sleep. Lancet 2002, 359:1207-1209.
57. Robinson RW, Zwillich CW, Bixler EO, et al.: Effects of oral narcotics on sleep-disordered breathing in healthy adults. Chest 1987, 91:197-203.
58. Aurell J, Elmqvist D: Sleep in the surgical intensive care unit: continuous polygraphic recording of nine patients receiving postoperative care. BMJ Clin Res Ed 1985, 290:1029-1032.
59. Rosenberg J, Rosenberg-Adamsen S, Kehlet H: Post-operative sleep disturbances: causes, factors and effects on outcome. Eur J Anaesthesiol 1995, 10 (suppl): 28-30.
60. Rosenberg J, Rasmussen GI, Wojdemann KR, et al.: Ventilatory pattern and associated episodic hypoxaemia in the late postoperative period in the general surgical ward. Anaesthesia 1999, 54:323-328.
61. Knill RL, Moote CA, Skinner MI, et al.: Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology 1990, 73:52-61.
62. Gupta R, Parvizi J, Hanssen A, et al.: Postoperative complications in patients with obstructive sleep apnea undergoing hip or knee replacement: a case-control study. Mayo Clin Proc 2001, 76:897-905.
63. Levin BC, Becker GD: UPPP for snoring: long-term results. Laryngoscope 1994, 104:1150-1152.
64. Benumof JL, Dagg R, Benumof R: Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 1997, 87:979-982.
65. Chesson Jr , AL Ferber RA, Fry JM, et al.: The indications for polysomnography and related procedures. Sleep 1997, 20:423-487.
66. Hoffstein V, Szalai JP: Predictive value of clinical features in diagnosing obstructive sleep apnea. Sleep 1993, 16:118-122.
67. Schäfer H, Ewig S, Hasper E, et al.: Predictive diagnostic value of clinical assessment and nonlaboratory monitoring system recordings in patients with symptoms suggestive of obstructive sleep apnea syndrome. Respiration 1997, 64:194-199.
68. Sinuff T, Cook D, Randall J, et al.: Noninvasive positive-pressure ventilation: a utilization review in a teaching hospital. CMAJ 2000, 163:969-973.
69. Criner GJ, Brennan K, Travaline JM, et al.: Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failure. Chest 1999, 116:667-675.
70. Chervin RD, Theut S, Bassetti C, et al.: Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997, 20:284-289.
71. Hoy CJ, Vennelle M, Kingshott RN, et al.: Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999, 159:1096-1100.
72. Berry RB, Parish JM, Hartse KM: The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. Sleep 2002, 25:148-173.
73. Rosen R, Mahowald M, Chesson A, et al.: The taskforce 2000 survey on medical education in sleep and sleep disorders. Sleep 1998, 21:235-238.